Durvalumab vs Hydromorphone

Durvalumab vs Hydromorphone: Overview

This comparison examines the pharmacological differences between Durvalumab and Hydromorphone.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Hydromorphone: Semisynthetic mu-opioid receptor agonist approximately 5 times more potent than morphine.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Hydromorphone — 2-3 hours.

Chemical Properties

Molecular Formula: Hydromorphone — C17H19NO3.

Molecular Weight: Hydromorphone — 285.3380 g/mol.

Type: Durvalumab — Antibody; Hydromorphone — Small molecule.